
Hong Kong’s PHASE Scientific raises $34m funding led by Value Partners Group
Hong Kong-headquartered PHASE Scientific, a biotech firm engaged in early disease detection through proprietary urine-based diagnostics, has snapped $34 million in a Series A funding round led by Hong Kong-listed asset management firm Value Partners Group …